Evidence map›Paper›PMID 35849052›Full record

ArticleHuman molecular genetics2022

Dynamics of the most common pathogenic mtDNA variant m.3243A > G demonstrate frequency-dependency in blood and positive selection in the germline.

Melissa Franco, Sarah J Pickett, Zoe Fleischmann, Mark Khrapko, Auden Cote-L'Heureux, Dylan Aidlen, David Stein, Natasha Markuzon, Konstantin Popadin, Maxim Braverman and 4 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Melissa FrancoDepartment of Biology, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0001-9943-6960
Sarah J PickettWellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University and Newcastle Medical School, Newcastle-upon-Tyne NE2 4HH, UK.ORCID 0000-0002-1242-2927
Zoe FleischmannDepartment of Biology, Northeastern University, Boston, MA 02115, USA.
Mark KhrapkoDepartment of Biology, Northeastern University, Boston, MA 02115, USA.
Auden Cote-L'HeureuxDepartment of Biology, Northeastern University, Boston, MA 02115, USA.
Dylan AidlenDepartment of Biology, Northeastern University, Boston, MA 02115, USA.
David SteinDepartment of Biology, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0002-5131-8313
Natasha MarkuzonDraper Laboratories, Cambridge, MA 02139, USA.
Konstantin PopadinSchool of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
Maxim BravermanDepartment of Mathematics, Northeastern University, Boston, MA 02115, USA.
Dori C WoodsDepartment of Biology, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0001-8917-8865
Jonathan L TillyDepartment of Biology, Northeastern University, Boston, MA 02115, USA.
Doug M TurnbullWellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University and Newcastle Medical School, Newcastle-upon-Tyne NE2 4HH, UK.
Konstantin KhrapkoDepartment of Biology, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0002-9250-8033

Funding

mtDNA phylogeny of the germ line: mechanism, structure and function of the mtDNA bottleneckR01HD091439 · NICHD · NORTHEASTERN UNIVERSITY · PI KHRAPKO, KONSTANTIN, TILLY, JONATHAN LEE · 2018 to 2022
$1.6M
NICHD NIH HHS R01 HD091439Wellcome TrustWellcome Trust 203105/Z/16/ZWellcome Trust 204709/Z/16/Z
6 · The paper itself

Abstract

The A-to-G point mutation at position 3243 in the human mitochondrial genome (m.3243A > G) is the most common pathogenic mtDNA variant responsible for disease in humans. It is widely accepted that m.3243A > G levels decrease in blood with age, and an age correction representing ~ 2% annual decline is often applied to account for this change in mutation level. Here we report that recent data indicate that the dynamics of m.3243A > G are more complex and depend on the mutation level in blood in a bi-phasic way. Consequently, the traditional 2% correction, which is adequate 'on average', creates opposite predictive biases at high and low mutation levels. Unbiased age correction is needed to circumvent these drawbacks of the standard model. We propose to eliminate both biases by using an approach where age correction depends on mutation level in a biphasic way to account for the dynamics of m.3243A > G in blood. The utility of this approach was further tested in estimating germline selection of m.3243A > G. The biphasic approach permitted us to uncover patterns consistent with the possibility of positive selection for m.3243A > G. Germline selection of m.3243A > G shows an 'arching' profile by which selection is positive at intermediate mutant fractions and declines at high and low mutant fractions. We conclude that use of this biphasic approach will greatly improve the accuracy of modelling changes in mtDNA mutation frequencies in the germline and in somatic cells during aging.

Indexed as

DNA, MitochondrialMitochondrial DiseasesGerm CellsHumansMitochondriaMutationPoint MutationDNA, Mitochondrial

Identifiers

PMID35849052
PMCPMC9703810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.